Skip to content

The Neuroinflammatory Response and Biomarkers in Acute Traumatic Spinal Cord Injury

The Neuroinflammatory Response and Biomarkers in Acute Traumatic Spinal Cord Injury: A Pilot Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03505463
Enrollment
30
Registered
2018-04-23
Start date
2018-05-01
Completion date
2020-12-01
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury, Acute

Keywords

Spinal cord injury, Biomarkers, Inflammation, Trauma

Brief summary

The study is a prospective cohort study designed to assess the diagnostic and prognostic potential of biomarker measurement in acute traumatic spinal cord injury (TSCI), and to examine the neuroinflammatory response to acute TSCI.

Detailed description

TSCI is an incurable condition with devastating consequences. The physical, psychosocial and financial implications in addition to a variable recovery and an uncertain prognosis have a profound impact on quality of life.The pathophysiology of TSCI is dual consisting of a primary injury and a secondary injury. The immediate trauma to the spinal cord and nerve roots causes the primary injury, while a prolonged cascade of events causes the secondary injury. The neuroinflammatory response is considered to be an important event. Current clinical measures to evaluate acute TSCI consist of clinical examination and routine imaging modalities. These measurements are inaccurate to assess injury severity, prognosis, and therapeutic efficacy, especially in the early acute phase. Biomarker measurement may provide a more accurate measure. This study aim to assess the diagnostic and prognostic potential of biomarker measurement in acute TSCI, and to examine the neuroinflammatory response to acute TSCI. To achieve this, immune cells, cytokines, autoantibodies and structural proteins will be analysed in blood and cerebrospinal fluid by Flow Cytometry and assay techniques. These analyses will be correlated to clinical outcome assessed according to international standards. Hopefully, this will contribute with new knowledge of the neuroinflammatory response and biomarkers in acute TSCI, and provide the needed knowledge for conducting futures trials in novel therapeutic interventions.

Interventions

OTHERBlood samples

Three blood samples will be collected from the injured participants. The assessment points are \<72 hours, 7 days and 365 days post-injury. One blood sample will be collected from the healthy participants. The collection will be performed as part of clinical diagnostic at the Department of Neurology at Aarhus University Hospital. Laboratory analysis of the collected samples comprise Flow Cytometry and assay techniques.

OTHERCerebrospinal fluid sample

Three cerebrospinal fluid samples will be collected from the injured participants. The assessment points are \<72 hours, 7 days and 365 days post-injury. The collected samples will be analysed by Flow Cytometry and assay techniques. One cerebrospinal fluid sample will be collected from the healthy participants. The collection will be performed as part of clinical diagnostic at the Department of Neurology at Aarhus University Hospital. Laboratory analysis of the collected samples comprise Flow Cytometry and assay techniques.

OTHERClinical examination

Clinical examinations will be performed at \<72 hours, 7 days and 365 days post-injury.

Sponsors

Aarhus University Hospital
CollaboratorOTHER
Spinal Cord Injury Centre of Western Denmark
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years

Inclusion criteria

* Traumatic spinal cord injury (Bony level C1-L1) * ISNCSCI score A-C upon inclusion. * Age \>18-70 years.

Exclusion criteria

* Prior major spine surgery in the traumatised location. * Major co-morbidities or co-injuries. * Penetrating spinal cord injury. * \>72 hours from injury to sample collection.

Design outcomes

Primary

MeasureTime frame
Change in International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)<72 hours, 7 days and 365 days post-injury.

Secondary

MeasureTime frameDescription
Walking Index for Spinal Cord Injury II (WISCI II)365 days post-injury
The Spinal Cord Independence Measure III (SCIM III)365 days post-injury
Visual Analogue Pain Score (VAS)365 days post-injuryVAS will be used to assess pain intensity. VAS is a scale ranging from 0 to 10 where No pain gives a score of 0 and worst imaginable pain gives a score of 10.
International Spinal Cord Injury Dataset for sexual function365 days post-injury
International Spinal Cord Injury Dataset for pain365 days post-injury
International Spinal Cord Injury Dataset for bladder365 days post-injury
International Spinal Cord Injury Dataset for bowel365 days post-injury
International Spinal Cord Injury Dataset for core365 days post-injury

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026